1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
1 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2025 | |
|---|---|---|
| Revenue | 198.76K | - |
| Gross profit | 198.76K | - |
| Net profit | -2.28M | - |
| EBITDA | -2.29M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €8.19B |
Number of shares | 97.78M |
52-week high/low | €83.80 - €0.0216 |
| Dividends | No |
Beta | 1.31 |
P/E ratio | -1.31 |
PEG ratio | 0.00 |
P/B ratio | 0.94 |
P/S ratio | 25.36 |
Company profile
| Name | Oncoinvent ASA |
| CEO | Oystein Soug |
| Employees | 13 |
Discover assets
Shareholders of Oncoinvent ASA also invest in the following assets
